Struggling With Great Stock Picks? Discover StockInvest.us Top Gems!

Range Low Price High Price Comment
30 days $14.87 $19.38 Friday, 10th May 2024 RGNX stock ended at $15.44. This is 1.53% less than the trading day before Thursday, 9th May 2024. During the day the stock fluctuated 10.42% from a day low at $14.87 to a day high of $16.42.
90 days $14.87 $28.80
52 weeks $11.83 $28.80

Historical REGENXBIO Inc. prices

Date Open High Low Close Volume
Jul 26, 2023 $17.69 $18.22 $17.56 $18.19 240 970
Jul 25, 2023 $17.95 $18.15 $17.70 $17.73 206 402
Jul 24, 2023 $18.21 $18.35 $17.76 $18.05 238 003
Jul 21, 2023 $18.24 $18.35 $17.86 $18.27 191 068
Jul 20, 2023 $18.15 $18.28 $17.67 $18.03 243 972
Jul 19, 2023 $18.47 $19.03 $18.31 $18.33 232 424
Jul 18, 2023 $18.59 $18.95 $18.26 $18.32 233 938
Jul 17, 2023 $18.84 $19.40 $18.59 $18.61 193 280
Jul 14, 2023 $19.14 $19.14 $18.55 $18.86 239 250
Jul 13, 2023 $19.38 $19.38 $18.88 $19.07 369 880
Jul 12, 2023 $20.23 $20.23 $19.20 $19.31 327 468
Jul 11, 2023 $19.88 $20.38 $19.47 $19.83 541 175
Jul 10, 2023 $19.40 $20.30 $19.35 $19.74 646 768
Jul 07, 2023 $19.50 $19.97 $19.01 $19.47 254 761
Jul 06, 2023 $18.82 $19.50 $18.45 $19.42 297 353
Jul 05, 2023 $20.06 $20.06 $18.83 $19.18 327 502
Jul 03, 2023 $19.83 $20.15 $19.71 $19.99 151 765
Jun 30, 2023 $20.12 $20.29 $19.65 $19.99 441 233
Jun 29, 2023 $20.34 $20.49 $19.69 $19.83 364 466
Jun 28, 2023 $19.79 $20.75 $19.48 $20.39 514 676
Jun 27, 2023 $18.47 $19.83 $18.24 $19.69 344 617
Jun 26, 2023 $18.87 $18.96 $18.41 $18.42 322 745
Jun 23, 2023 $19.06 $19.44 $18.62 $18.90 357 121
Jun 22, 2023 $19.16 $19.75 $18.81 $19.32 359 502
Jun 21, 2023 $20.28 $20.32 $18.89 $19.33 330 496
Click to get the best stock tips daily for free!

About REGENXBIO Inc.

REGENXBIO. REGENXBIO Inc., a clinical-stage biotechnology company, provides gene therapy product candidates to deliver genes to cells to address genetic defects or to enable cells in the body to produce therapeutic proteins or antibodies that are intended to impact disease. Its gene therapy product candidates are based on NAV Technology Platform, a proprietary adeno-associated virus gene delivery platform. The company's lead product candidate is RGX-314, wh... RGNX Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT